Receptos

About:

Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.

Top Investors: OrbiMed, Flagship Pioneering, Polaris Partners, Venrock, OUP (Osage University Partners)

Description:

Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.

Total Funding Amount:

$103M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)receptos.com

Founders:

Fred Aslan, Hugh Rosen, Kristina Burow, Marcus F. Boehm, Raymond E. Stevens, Robert J. Peach, William Rastetter

Number of Employees:

51-100

Last Funding Date:

2014-11-24

IPO Status:

Delisted

Industries: